Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Endocyte Inc (NASDAQ:ECYT)

3.28
Delayed Data
As of 10:59am ET
 +0.07 / +2.18%
Today’s Change
2.65
Today|||52-Week Range
5.87
-18.20%
Year-to-Date
No recent news for Endocyte Inc.

Today’s Trading

Previous close3.21
Today’s open3.21
Day’s range3.21 - 3.31
Volume16,672
Average volume (3 months)172,869
Market cap$135.3M
Dividend yield--
Data as of 10:59am ET, 07/01/2016

Growth & Valuation

Earnings growth (last year)-853.85%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-99.90%
P/E ratioNM
Price/Sales2,402.53
Price/Book0.79

Competitors

 Today’s
change
Today’s
% change
ARQLArQule Inc-0.04-2.11%
CLSDClearside Biomedical...-0.25-3.56%
EIGREiger BioPharmaceuti...+0.30+1.51%
RDHLRedhill Biopharma Lt...+0.04+0.32%
Data as of 11:00am ET, 07/01/2016

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$70.0K
Annual profit (last year)-$41.3M
Net profit margin-58,956.78%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, CFO &
Director
Michael A. Sherman
Director &
Chief Science Officer
Philip S. Low
Corporate headquarters
West Lafayette, Indiana

Forecasts

Partner Offers

Search for Jobs